ARTISTRY-6
04 May 2022
ARTISTRY-6
NCT04830124
Nemvaleukin Alfa (ALKS 4230) Monotherapy in Patients With Advanced Cutaneous Melanoma or Advanced Mucosal Melanoma – ARTISTRY-6
Alkermes, Inc.
Cancer Type | Melanoma & other skin |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | Locally Advanced |
Anticipated Start Date | 2021-05-27 |
Anticipated End Date | 2025-09-01 |
Hospital | The Queen Elizabeth Hospital |
---|---|
Clinical Trial Coordinator | Stella Papacharissiou |
stella.papacharissiou@sa.gov.au | |
Phone | 08 8222 6410 |
Principal Investigator | Dr Rachel Roberts-Thomson |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs